Minfeng Huo Selected Research

Minfeng Huo Research Topics

Disease

19	Neoplasms (Cancer) 12/2023 - 01/2016
4	Hyperthermia 08/2021 - 01/2019
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 12/2021
2	Reperfusion Injury 01/2023 - 11/2021
2	Infections 10/2022 - 01/2019
2	Bacterial Infections (Bacterial Infection) 10/2022 - 01/2019
2	Hypoxia (Hypoxemia) 12/2021 - 01/2018
1	Starvation 02/2023
1	Colorectal Neoplasms (Colorectal Cancer) 02/2023
1	Cardiotoxicity 12/2022
1	Iron Overload 12/2022
1	Bacterial Pneumonia 10/2022
1	Cytokine Release Syndrome 10/2022
1	Inflammation (Inflammations) 10/2022
1	Bites and Stings (Sting) 01/2022
1	Fabry Disease (Fabry's Disease) 01/2022
1	Vision Disorders (Hemeralopia) 12/2021
1	Macular Degeneration (Age-Related Maculopathy) 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2021
1	Retinal Diseases 12/2021
1	Photosensitivity Disorders (Photodermatitis) 10/2021
1	Osteosarcoma (Osteogenic Sarcoma) 08/2021
1	Alcoholism (Alcohol Abuse) 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Hereditary Sensory and Motor Neuropathy (Dejerine Sottas Disease) 01/2018
1	Breast Neoplasms (Breast Cancer) 11/2017

Drug/Important Bio-Agent (IBA)

6	IronIBA 12/2022 - 01/2017
6	Hydroxyl RadicalIBA 08/2021 - 01/2017
4	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 01/2017
3	Silicon Dioxide (Silica)FDA LinkGeneric 01/2019 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022 - 11/2017
2	hexacyanoferrate II (ferrocyanide)IBA 12/2022 - 10/2022
2	Biocompatible Materials (Biomaterials)IBA 12/2021 - 08/2021
2	Singlet OxygenIBA 10/2021 - 01/2020
2	Oxygen (Dioxygen)IBA 10/2021 - 01/2020
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 01/2018
1	catechol (pyrocatechol)IBA 12/2023
1	Glucose 1-DehydrogenaseIBA 02/2023
1	CeriumIBA 01/2023
1	Tannic Acid FDA Link 01/2023
1	Coordination ComplexesIBA 01/2023
1	Cardiotonic Agents (Cardiac Stimulants)IBA 12/2022
1	MagnesiumIBA 12/2022
1	Povidone (Crospovidone)IBA 12/2022
1	AnthracyclinesIBA 12/2022
1	ZincIBA 10/2022
1	ferric ferrocyanide (Prussian blue)FDA Link 10/2022
1	GalactosidasesIBA 01/2022
1	InterferonsIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 12/2021
1	Retinaldehyde (Retinal)IBA 12/2021
1	polydopamineIBA 11/2021
1	Phosphorus (Red Phosphorus)IBA 10/2021
1	3-methyladenineIBA 04/2021
1	protoporphyrin IXIBA 04/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020
1	Photosensitizing Agents (Photosensitizers)IBA 01/2020
1	MXeneIBA 11/2019
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2019
1	IridiumIBA 11/2019
1	IntegrinsIBA 11/2019
1	Arginine (L-Arginine)FDA Link 11/2019
1	Trans-Activators (Trans-Acting Factor)IBA 11/2019
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2019
1	Peptides (Polypeptides)IBA 11/2019
1	Syntex adjuvant formulationIBA 01/2019
1	hydroxide ionIBA 01/2019
1	CopperIBA 01/2019
1	Disulfiram (Antabuse)FDA Link 01/2019
1	Therapeutic UsesIBA 01/2019
1	Lipid PeroxidesIBA 01/2019
1	EnzymesIBA 01/2017

Therapy/Procedure

20	Therapeutics 12/2023 - 01/2016
3	Drug Therapy (Chemotherapy) 12/2022 - 01/2018
3	Photochemotherapy (Photodynamic Therapy) 10/2021 - 01/2018
2	Photothermal Therapy 11/2021 - 01/2019
2	Lasers (Laser) 10/2021 - 01/2020
2	Radiotherapy 11/2019 - 01/2018
1	Immunomodulation 01/2022
1	Intravenous Injections 01/2016